SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors react to a significant $2 million insider share purchase by board directors and a double earnings beat that led to upward revenue guidance adjustments. While some community members remain frustrated by the stock's long-term price stagnation, others are highlighting the company's dividend yield and defensive positioning as attractive relative to broader market volatility.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as market participants weigh persistent concerns over rising global bond yields and geopolitical tensions in the Middle East against ongoing AI infrastructure capital expenditure. Community sentiment remains deeply divided, with traders closely monitoring key support levels and dealer gamma positioning while debating whether the current pullback represents a healthy consolidation or a systemic credit risk.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors digest the positive long-term impact of a major settlement with Samsung and anticipate further licensing deals with memory industry peers. The community is actively discussing the pressure this creates for Micron, potential upcoming Federal Circuit developments, and the stock's transition from a long-running legal battle to a potential leader in AI-essential memory technology.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending as investors reassess broad-market exposure amid ongoing debates over U.S. economic stability, shifting interest rate expectations, and the sustainability of high-valuation tech-driven growth. Community discourse remains centered on whether broad index funds provide a necessary buffer against sector-specific volatility or if targeted growth strategies offer better protection in the current macroeconomic environment.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as investors react to a rival $37.50 per share buyout bid from an Israeli firm, which surpasses the existing $35 offer from Hapag-Lloyd and potentially bypasses national security concerns regarding the state's 'golden share.' Community discussion is buzzing over the possibility of a bidding war, the potential for continued dividend distributions during the buyout period, and strong underlying shipping fundamentals.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is facing heightened scrutiny as community discussions weigh strong revenue growth and expanded institutional backing against ongoing concerns regarding high cash burn and potential further dilution. Investors are actively debating the company's long-term commercial potential and management execution while monitoring the stock's recent volatility following a capital raise.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are closely debating potential downside risks and a possible correction, driven by concerns over rising bond yields, energy costs, and geopolitical uncertainty in the Strait of Hormuz. Community sentiment is deeply divided, with traders focused on whether recent trade-related news will act as a temporary floor or if the index is setting up for a significant test of lower support levels.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is drawing significant investor attention due to aggressive institutional interest in long-term call options, reinforcing the bullish narrative surrounding its critical role in supplying gas turbines and grid infrastructure for AI data centers. While the stock has experienced recent volatility and pullback, the community remains heavily focused on the company's record backlog, robust free cash flow, and its status as a foundational beneficiary of the multi-year AI power infrastructure buildout.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is attracting strong attention as investors rotate into value-oriented pharmaceutical stocks, driven by solid earnings performance and successful pipeline execution. The community is actively discussing the company's growth portfolio performance, potential acquisition strategies, and its defensive positioning compared to higher-volatility sectors.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems shares are experiencing significant volatility following a mixed earnings report where revenue fell short of consensus expectations despite raised full-year guidance. Investors are actively debating the company's valuation, the impact of upcoming share lock-up expirations, and the sustainability of its growth trajectory in the competitive AI hardware landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fabrinet Q4 Earnings Beat Estimates on Strong Data Center Growth

FN's Q4 earnings and revenues beat estimates as data center sales surge 68%, with DCI topping a $1 billion annualized run rate.

Synopsys (SNPS) Gains As Market Dips: What You Should Know

Synopsys (SNPS) concluded the recent trading session at $421.5, signifying a +2.37% move from its prior day's close.

CDNS Falls 12.9% in the Past Month. Is the Sell-Off an Opportunity?

CDNS has fallen 12.9% in a month despite strong Q2 growth, as a lower valuation and AI demand clash with a still-steep premium.

Cadence Raises 2026 Outlook as AI Agents Drive Broader EDA Demand

CDNS raises its 2026 outlook as AI demand expands across EDA, hardware and IP, while record backlog and agentic AI engagements bolster growth.

Is Cadence Worth Buying as AI Growth Collides With Premium Valuation?

Cadence pairs rising AI-driven design demand, higher earnings expectations and stronger cash flow with a valuation still well above key benchmarks.

OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates

OptimizeRx (OPRX) delivered earnings and revenue surprises of +45.46% and +0.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Can SNPS Leverage AI to Accelerate Chip Design and Drive Growth?

Synopsys is leveraging AI across chip design, verification and simulation, driving productivity gains and strengthening its position in the AI semiconductor value chain.

Should You Hold or Fold SNPS Stock After a 20% Decline in 3 Months?

Synopsys' AI infrastructure exposure, recurring revenues and Ansys acquisition support growth despite the stock's recent 20% decline.

Synopsys (SNPS) Unleashes Agentic AI Chip Design Tools Backed by Microsoft, AMD

Synopsys (SNPS) Unleashes Agentic AI Chip Design Tools Backed by Microsoft, AMD...

Synopsys (SNPS) Increases Despite Market Slip: Here's What You Need to Know

Synopsys (SNPS) concluded the recent trading session at $405.98, signifying a +1.29% move from its prior day's close.

$SNPS Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.09 down -95.96% YoY
• Reported revenue of $2.28B up 41.87% YoY
• Synopsys raised its full-year total revenue guidance to $9.665 billion at the midpoint and non-GAAP EPS guidance to $14.76 at the midpoint for fiscal year 2026, driven by strong performance and expanded operating margin.

Synopsys, Inc. engages in the provision of electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). It also offers semiconductor intellectual property (IP) products. It operates through the Design Automation and Design IP segments. The Design Automation segment includes silicon design, verification of products and services, and Ansys products, and system integration of products and services. The Design IP segment refers to interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services that serve companies primarily in the semiconductor and electronics industries. The company was founded by Aart J. de Geus, Bill Krieger, Dave Gregory, and Rick Rudell in December 1986 and is headquartered in Sunnyvale, CA.

Synopsys, Inc.

ATOM Stock Soars Toward Record Month: Synopsys Collaboration Fuels Retail Hype

Equity

Bearish Sentiment

Track SNPS stock price, charts, news and real-time market activity on Stocktwits. Join the SNPS message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Synopsys Inc stock.

SNPS Stock Price Today - Synopsys Inc News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SNPSSynopsys Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest SNPS News